A decrease in the ratio DNAM-1+/DNAM-1− NK cells was also reported in patients diagnosed with Hodgkin lymphoma and diffuse large B-cell lymphoma, corresponding to low expression of DNAM-1 in NK cells with a terminally differentiated phenotype with reduced cytotoxic activity [29]. The gene discussed is CD226; the disease is Hodgkins lymphoma.